PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1305944
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1305944
Global Infection Control Supplies Market size will expand significantly through 2032. Rapid expansion of healthcare facilities is creating a notable impetus for market expansion. The expanding healthcare infrastructure, including hospitals, clinics, and long-term care facilities, increases the demand for infection control supplies. With the establishment of new facilities or the development of existing ones, the need to equip these spaces with the necessary supplies to maintain a sterile environment and prevent the spread of infections stands critical.
The overall infection control supplies market is categorized based on product, distribution channel, end-use, and region.
Based on product, the cleaning and disinfection equipment industry size will expand substantially through 2032. The increasing number of catheter-acquired urinary tract infections, in tandem with the growing financial burden associated with hospital-acquired infections, is paving the path for segment growth. As per NCBI, around 1 million cases of catheter-associated urinary tract infections (CAUTI) are diagnosed every year in the U.S. alone. Additionally, the associated cost of preventable CAUTI lies between the range of USD 115 million to USD 1.82 billion every year.
Based on the distribution channel, industry value from the e-commerce segment will depict substantial gains through 2032. Rising inclination of customers towards e-commerce channels owing to their convenience and cost-effectiveness is contributing to segment growth. Moreover, these platforms have high availability of a wide range of infection control supplies at discounted prices, which makes them suitable for the middle-class population. The rise in the number of e-commerce platforms is further creating a notable impetus for segment growth.
Based on the end-use, industry share from the medical device companies segment will grow at over 6% CAGR from 2023 to 2032. A surge in U.S. FDA approval of sterilization products has increased demand for infection control supplies in medical device companies. Moreover, tightening regulatory scenarios for infection control in healthcare settings has further increased the adoption of infection control supplies in these facilities.
From the regional standpoint, Europe infection control supplies market size will reach over USD 17 billion by 2032. Rising prevalence of chronic disorders attributed to the growing geriatric population is contributing to regional growth. Moreover, the robust presence of industry players such as Getinge Ab, Belimed Deutschland GmbH, and others is further working in favor of regional growth. Additionally, Europe has a well-established healthcare infrastructure that will support industry growth.